Marker Therapeutics, Inc.

Tagged: car-tcr summit

Marker Therapeutics to Present at the CAR-TCR Summit Europe

President and CEO, Peter L. Hoang, and Chief Development Officer, Dr. Juan Vera, will be presenting at the CAR-TCR Summit Europe.

Read More

TapImmune to Participate at Two Upcoming Industry Conferences

Peter L. Hoang will be participating in two industry conferences next week.

Read More